Literature DB >> 1371541

Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs.

J T Saliki1, B Mizak, H P Flore, R R Gettig, J P Burand, L E Carmichael, H A Wood, C R Parrish.   

Abstract

The VP-2 genes of canine parvovirus (CPV) and a recombinant consisting of CPV and feline panleukopenia virus (FPV) sequences were cloned into baculovirus expression vectors, fused to the baculovirus polyhedrin promoter. Recombinant baculoviruses were prepared and the properties of the parvovirus proteins expressed in insect cells examined. The proteins produced were the same size as the authentic CPV VP-2 protein, and were produced late after infection; the quantity of proteins recovered from the insect cell cultures was similar to those produced in CPV infections. Parvovirus particles formed had the haemagglutination (HA), sedimentation and buoyant density properties of authentic CPV capsids. Both the CPV capsids and the CPV-FPV recombinant capsids from the baculovirus system expressed the same epitopes as those seen in the viable parvoviruses when tested with a panel of anti-parvovirus monoclonal antibodies. Lysates of recombinant baculovirus-infected cells were inoculated into dogs, giving rise to serum neutralizing and HA-inhibiting antibodies, and the immunized dogs were protected from clinical disease upon challenge with a virulent isolate of the most recent antigenic type of CPV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371541     DOI: 10.1099/0022-1317-73-2-369

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  25 in total

1.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein.

Authors:  X Jiang; M Wang; D Y Graham; M K Estes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Parvovirus diagnostics and vaccine production in insect cells.

Authors:  J I Casal
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

3.  Visualization of the externalized VP2 N termini of infectious human parvovirus B19.

Authors:  Bärbel Kaufmann; Paul R Chipman; Victor A Kostyuchenko; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

4.  First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

Authors:  J P Langeveld; J I Casal; A D Osterhaus; E Cortés; R de Swart; C Vela; K Dalsgaard; W C Puijk; W M Schaaper; R H Meloen
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Identification of a cell surface protein from Crandell feline kidney cells that specifically binds Aleutian mink disease parvovirus.

Authors:  J M Fox; M E Bloom
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Serodiagnosis of mice minute virus and mouse parvovirus infections in mice by enzyme-linked immunosorbent assay with baculovirus-expressed recombinant VP2 proteins.

Authors:  Robert S Livingston; David G Besselsen; Earl K Steffen; Cynthia L Besch-Williford; Craig L Franklin; Lela K Riley
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

7.  Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells.

Authors:  M Ruffing; H Zentgraf; J A Kleinschmidt
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera.

Authors:  M M Hulst; D F Westra; G Wensvoort; R J Moormann
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Expression of Aleutian mink disease parvovirus proteins in a baculovirus vector system.

Authors:  J Christensen; T Storgaard; B Bloch; S Alexandersen; B Aasted
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.

Authors:  R C Rose; W Bonnez; R C Reichman; R L Garcea
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.